A:

Government regulation lengthens the process for bringing new pharmaceuticals to market and restricts the drugs sector to protect public safety. Governments create incentives for particular behaviors and encourages the development of safe and effective drugs. Pharmaceutical companies are heavily regulated to ensure they are in compliance with federal safety laws. In the United States, the Food and Drug Administration (FDA) ensures that new drugs are rigorously tested for safety, efficacy and minimal side effects.

As a result of this testing, most new drugs are researched and investigated for 10 to 15 years before they are brought to market. Drugs must undergo human trials that are intended to discover potential side effects and treatment efficacy. At any point in the multi-phase testing process, new drugs may fail to show effectiveness or may have unreasonable side effects. If either of these occurs, the company may research it further in the lab at its own expense but will not receive permission to release it to the market until the product yields positive results in human trials.

Research and Development

Throughout this period of research and development, pharmaceutical companies must have dependable sources of financing. Typically, this financing is in the form of either investments and loans or revenue from sales of other products. Government regulation gives a distinct competitive advantage to companies large enough to maintain secure funding. Major drug manufacturers with profitable products already in the market usually do not require the ongoing fundraising and venture capital that startups do.

This process is a significant barrier to entry in the pharmaceutical industry. As a result, mergers and acquisitions (M&As) are common. New companies and larger companies both benefit from mergers. Big companies take advantage of opportunities to acquire profitable new products and small companies benefit from the financial boost and expertise of a large partner. Because of the regulatory expense, companies have a strong incentive to offer support to only the most promising drugs. M&As usually happen only after new drugs begin to show promise in trials.

Orphan Drugs

Some drugs benefit from additional government incentives. Orphan drugs receive special consideration from the FDA in order to encourage pharmaceutical companies to develop treatments for rare diseases. Incentives for the development of orphan drugs include quicker approval time and potential financial assistance for development. Companies are often permitted to charge substantial prices for orphan drugs, making them more profitable than they would be without government intervention. As a result, the development of orphan drugs continues to grow at a faster rate than the development of traditional pharmaceuticals.

Overall, government regulation of the drug sector has resulted in a longer, more-expensive product development process that favors treatments for rare illnesses. All approved drugs have been rigorously tested by the FDA to protect consumers from harmful or ineffective treatments. This process is designed to occur over a long period of time to ensure that only the safest and most effective drugs arrive on the market.

RELATED FAQS
  1. What Are Barriers to Entry for Pharma Companies?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ... Read Answer >>
  2. Do financial advisors get drug tested?

    Financial advisor regulatory bodies do not require drug testing, but many individual firms that hire advisors do. Read Answer >>
  3. Can your insurance company drug test you?

    Learn why insurance companies conduct drug tests and how a lifestyle free of drugs can save you big money on health and life ... Read Answer >>
  4. Who Are Pfizer's (PFE) Main Competitors?

    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ... Read Answer >>
  5. Biotech vs Pharmaceutical company

    Though biotech and pharmaceutical companies share similar business features, there also have differences. Here, we'll distinguish ... Read Answer >>
  6. How does research and development differ from product development?

    Research and development is the conception phase of a product, while product development is the process of designing, creating, ... Read Answer >>
Related Articles
  1. Investing

    Senator Orders Investigation of Orphan Drug Abuse

    Iowa Senator Grassley ordered an inquiry into possible abuse of the Orphan Drug Act by drug makers.
  2. Investing

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  3. Investing

    Using DCF In Biotech Valuation

    Valuing firms in this sector can seem like a black art, but there is a systematic way to pin a price on potential.
  4. Investing

    Where Does the US Get Its Supply of Drugs?

    Despite increasing demands for local production, the US imports only a small portion of its drugs.
  5. Investing

    A Biotech Sector Primer

    Investing in biotechs can involve both huge losses and major gains. Learn about the industry that focuses on novel drug development and clinical research.
  6. Insurance

    Big Pharma: Will Price Pressure Happen No Matter What?

    Watch out for a possible decline in pharmaceutical stock prices, thanks to a renewed debate about the role of government policy and macroeconomic headwinds.
  7. Investing

    PJP: PowerShares Dynamic Pharmaceuticals ETF

    Learn about the PowerShares Dynamic Pharmaceuticals exchange-traded fund, which specializes on investing in pharmaceutical companies.
  8. Investing

    Drug Giants May Benefit From China Drug Inclusion

    Pharma giants may see higher sales as the Chinese government subsidizes expensive prescription drugs.
  9. Investing

    Cost of Old Cancer Drugs Rises in EU Amid Outcry

    The prices of several off-patent cancer drugs have soared more than 100% in Europe.
  10. Insights

    Why Drug Prices Keep Rising & How to Fight Back

    Despite pushback from politicians and disgruntled consumers, the cost of drugs keeps going up. Is there any relief on the horizon?
RELATED TERMS
  1. New Drug

    New drug is an original or innovative medication or therapy that ...
  2. Orphan Drug Credit

    The orphan drug credit helps pharmaceutical companies absorb ...
  3. Phase 4

    Phase 4 refers to the final stage of new drug testing, which ...
  4. Side Effect

    Side effect is a negative or undesirable symptom or condition ...
  5. Phase 2

    Phase 2 is the second phase of clinical trials for an experimental ...
  6. Pharmacovigilance

    Pharmacovigilance refers to the scientific process through which ...
Trading Center